YATHARTH981.10

Yatharth Hospital & Trauma Care Services Ltd.

· Pharma & Health
₹ CrorePeersMAXHEALTHMEDANTAFORTISVIYASHTHYROCARESUPRIYASTARSPARCMcap ₹9,453 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation29.357.287.8
+ Impairment Loss / (Reversal)0.00.020.2
+ Finance Costs9.47.55.3
+ Interest Income-12.5-7.8-19.5
+ Fair Value (Gains) / Losses0.0-2.9-2.8
+ Other Non-cash Items0.00.0-3.4
+ Other — Cash Effects are Investing / Financing0.00.0-4.6
Changes in Working Capital
+ Inventories-1.9-12.80.3
+ Trade Receivables — Current-119.2-74.5-92.0
+ Other Financial Assets — Current0.00.0-0.6
+ Other Financial Assets — Non-current0.027.10.0
+ Other Current Assets-31.10.0-4.4
+ Trade Payables — Current0.00.080.7
+ Other Financial Liabilities — Current0.00.0-9.5
+ Other Financial Liabilities — Non-current0.08.60.0
+ Other Current Liabilities9.20.02.0
+ Provisions — Current0.70.03.6
+ Provisions — Non-current0.02.00.0
Cash from Operating Activities
Profit Before Tax (per I/S)156.8171.7223.6225.1
+ Total Adjustments (incl. Working Capital)-116.24.563.0
Cash from Operations (pre-tax)40.7176.2286.6
+ Income Taxes Paid43.726.682.1
Cash from Operating Activities-3.1149.6204.5
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)93.4310.8316.5
+ Acq of Investment Property0.0-47.00.0
+ Disp of Investment Property0.00.0-48.0
+ Acq of Other Long-term Assets0.074.50.0
+ Purchase of Investments (Equity / Debt)0.00.01.7
+ Acq of Subsidiaries / Businesses (net)20.192.5251.0
+ Interest Received — Investing12.57.819.2
+ Other Inflows / (Outflows) — Investing-124.92.90.0
Cash from Investing Activities-225.9-420.2-598.0
Cash from Financing Activities
+ Proceeds from Issue of Shares576.8600.30.0
+ Proceeds from Borrowings-263.10.0262.3
+ Repayment of Borrowings0.073.30.0
+ Payment of Lease Liabilities0.00.03.4
+ Interest Paid0.07.53.7
+ Other Inflows / (Outflows) — Financing-9.40.0-1.7
Cash from Financing Activities304.2519.5253.5
Net Changes in Cash (pre-FX)75.3248.9-140.0
Net Changes in Cash75.3248.9-140.0
Closing Cash112.7
Reference Items
EBITDA179.9220.2292.1310.4
EBITDA Margin %26.8325.0124.2023.26
Free Cash Flow (CFO − Capex)-96.4-161.2-112.0-112.0
Free Cash Flow to Equity-251.8137.7
Free Cash Flow per Basic Share-10.01-16.73-11.63-11.63
Cash Flow to Net Income-0.031.151.20
Cash Paid for Taxes43.726.682.1
Cash Paid for Interest0.07.53.7
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.